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its association with proliferating cell nuclear antigen
Abstract
DNA polymerase (Pol) lambda is a member of the Pol X family and possesses four different enzymatic
activities, being DNA polymerase, terminal transferase, deoxyribose phosphate lyase and polynucleotide
synthetase, all localized in its C-terminal region. On the basis of its biochemical properties, Pol lambda
has been implicated in various DNA repair pathways, such as abasic site translesion DNA synthesis,
base excision repair and non-homologous end joining of double strand breaks. However, its role in vivo
has not yet been elucidated. In addition, Pol lambda has been shown to interact with the replication
clamp proliferating cell nuclear antigen (PCNA) in vitro and in vivo. In this work, we searched by
affinity chromatography for novel partners and we identified the cyclin-dependent kinase Cdk2 as novel
partner of Pol lambda. Pol lambda is phosphorylated in vitro by several Cdk/cyclin complexes,
including Cdk2/cyclin A, in its proline-serine-rich domain. While the polymerase activity of Pol lambda
was not affected by Cdk2/cyclin A phosphorylation, phosphorylation of Pol lambda was decreased by
its interaction with PCNA. Finally, Pol lambda is also phosphorylated in vivo in human cells and this
phosphorylation is modulated during the cell cycle.
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ABSTRACT
DNA polymerase (Pol) l isa memberof the Pol X family
and possesses four different enzymatic activities,
being DNA polymerase, terminal transferase, deoxy-
ribose phosphate lyase and polynucleotide syn-
thetase, all localized in its C-terminal region. On the
basis of its biochemical properties, Pol l has been
implicated in various DNA repair pathways, such as
abasic site translesion DNA synthesis, base excision
repair and non-homologous end joining of double
strand breaks. However, its role in vivo has not yet
been elucidated. In addition, Pol l has been shown
to interact with the replication clamp proliferating cell
nuclear antigen (PCNA) in vitro and in vivo. In this
work, we searched by affinity chromatography for
novel partners and we identified the cyclin-
dependent kinase Cdk2 as novel partner of Pol l.
Pol l is phosphorylated in vitro by several Cdk/cyclin
complexes, including Cdk2/cyclin A, in its proline-
serine-rich domain. While the polymerase activity of
Pol l was not affected by Cdk2/cyclin A phosphoryla-
tion, phosphorylation of Pol l was decreased by
its interaction with PCNA. Finally, Pol l is also phos-
phorylated in vivo in human cells and this phos-
phorylation is modulated during the cell cycle.
INTRODUCTION
Cell cycle progression is regulated by a family of cyclin-
dependent kinases (Cdks) which phosphorylate and activate
proteins that execute events critical to cell cycle progression.
For activity, Cdks require association with a cyclin and
phosphorylation by a Cdk activating kinase (CAK) at a con-
served threonine residue (1). Each phase of the cell cycle is
characterized by the expression of different Cdk/cyclin com-
plexes that phosphorylate and regulate downstream substrates.
In vertebrates, Cdk4/6/cyclin D complexes are active through-
out the G1 phase, Cdk2/cyclin E at the G1/S boundary, Cdk2/
cyclin A during S phase and Cdk1/cyclin A and Cdk1/cyclin B
during the G2/M transition. Studies using knockout mice (2–4)
revealed that neither Cdk2 nor cyclin E is essential for mitotic
cell division. Cyclin E seems to be important for the control of
endoreplication and for quiescent cells which re-enter in cell
cycle. Furthermore, Cdk2 is essential in the regulation of the
meiotic cell cycle, suggesting a novel tissue-specific function
for cyclins and Cdks.
Human DNA polymerase (Pol) l belongs to the Pol X
family based on sequence homology with Pol b, Pol m and
terminal deoxynucleotidyl transferase (5). Pol l contains
a nuclear localization signal (residues 1–35), a BRCA1
C-terminal domain (BRCT, residue 36–132), a proline-
serine-rich region (residues 133–243) and a Pol b-like core
region (residues 244–575). Pol l has been well characterized
in vitro and it possesses four different enzymatic activities:
DNA polymerase, terminal transferase, deoxyribose phos-
phate lyase and polynucleotide synthetase, all localized in
its C-terminal region (6–8). On the basis of its biochemical
properties, Pol l has been proposed to be involved in various
DNA repair pathways, such as abasic site translesion DNA
synthesis (9,10), base excision repair (11,12), repair of oxid-
ative DNA damage (13) and non-homologous end joining of
double strand breaks (DSBs) (14,15). In addition, Pol l has
been shown to interact with the replication clamp proliferating
cell nuclear antigen (PCNA) (9,16) and with the DNA repair
protein ligase IV/XRCC4 (17). Mapping of Pol l interaction
with PCNA identified a helix–hairpin–helix motif localized
in its Pol b-like core region (16). The major sites of interaction
between PCNA and many of its partners are the interdomain
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connecting loop (ID-loop) (amino acids 121–132) and the
facing hydrophobic pocket (amino acids 42–46) of PCNA
(18,19). We have recently shown that residues 43–45 of the
hydrophobic pocket are also essential for the interaction with
Pol l (16). In addition, residues 125–128 of the ID-loop also
play an important role in stabilizing this interaction (16).
Furthermore, interaction of Pol l with PCNA has also been
demonstrated in vivo (16,20). On the other hand, the in vivo
role of Pol l is so far poorly understood. To better understand
the Pol l function, we searched by affinity chromatography for
novel partners. We identified the cyclin-dependent kinase
Cdk2 as novel partner of Pol l. Pol l is a substrate for phos-
phorylation by several Cdk/cyclin complexes in vitro and its
proline-serine-rich domain is the target of phosphorylation by
Cdk2/cyclin A. Moreover, the phosphorylation of Pol l by
Cdk2/cyclin A is decreased upon interaction of Pol l with
PCNA. Finally, we demonstrated that Pol l is phosphorylated
in vivo and this phosphorylation is regulated during the cell
cycle.
MATERIALS AND METHODS
Chemicals
[g-32P]ATP (3000 mCi/mmol) and unlabeled ATP were pur-
chased from Amersham Biosciences, DNA oligonucleotides
from Microsynth Gmbh (Balgach, Switzerland). All other
reagents were from Merck, Fluka or Sigma.
Enzymes and proteins
Recombinant human wild-type Pol l was expressed and puri-
fied as described by Ramadan et al. (7). Human recombinant
PCNA was purified as previously described. The SHV43 mut-
ant of human PCNA was generated, expressed in Escherichia
coli and purified as described previously (21). The pGEX-3X
plasmids expressing human wild-type Cdk2 GST fusion pro-
tein was kindly provided by C. Bonne-Andre´a. The purified
Cdk2/cyclin E, Cdk2/cyclin A, Cdk1/cyclin A complexes (22)
were gifts from H. P. Nasheuer (Jena, Germany). Histone H1
was purchased from Roche.
DNA substrate
The sequence of the d73mer is : 50GATCGGGAGGGTAG-
GAATATTGAGGATGAAGGGTTGAGTTGAGTGGAGA-
TAGTGGAGGGTAGTATGGTGGATA30. The sequence
complementary to the 17mer primer is underlined.
Cell culture
HeLa cells were grown as monolayers in DMEM (Gibco)
supplemented with 10% fetal bovine serum (Gibco), 10 mg/ml
antibiotics (penicillin and streptomycin) at 37C in a humidi-
fied atmosphere containing 5% CO2. Synchronization of
HeLa cells at the G1/S border was obtained by growing
cells in 2 mM thymidine as described by Stein (23). After
thymidine removal, cells were washed twice with PBS, har-
vested immediately (G1/S border) or were further cultured in
complete medium for 3 h (S phase), 6 h (late S phase), 9 h (G2
phase) or 12 h (G2/M phase). Synchronization in M phase was
obtained by growing cells in nocodazole (40 ng/ml) for 20 h.
After nocodazole removal, cells were washed twice with
phosphate-buffered saline (PBS), harvested immediately
(M phase) or were further cultured in complete medium for
4 h (G1 phase). Cells were subsequently harvested and washed
three times with PBS and were pelleted by low-speed centri-
fugation (250 g, 5 min, 4C), and the cell pellets stored
at 80C until further use.
Preparations of cell extracts for DNA polymerase l
western blots
HeLa cells were washed twice with cold PBS. Then, 500 ml of
Laemmli buffer without b-mercaptoethanol were added to lyse
the cells. The lysed cells were scraped off the dish and the
DNA was shared by using a syringe. b-mercaptoethanol
(1.25%) and bromophenol blue (0.005%) were added and
the samples were incubated for 5 min at 95C.
Affinity chromatography
His-Pol l or BSA were covalently bound to a HiTrap NHS-
activated Sepharose High performance column (Amersham
Biosciences) according to the manufacturer’s instructions.
HeLa cells were lysed for 15 min in a high salt buffer
[100 mM HEPES, pH 7.5, 400 mM NaCl, 1 mM DTT, 2 mM
phenylmethylsulfonyl fluoride (PMSF), 20% glycerol, 0.5%
NP-40, 10 mM glycerophosphate, 1 mM Na3VO4, 1 mM NaF,
2 mg/ml leupeptin, 1 mg/ml pepstatin and 1 mg/ml bestatin] and
centrifuged for 10 min at 10 000 g at 4C, and the supernatant
was kept as the total extract. The total extract was diluted 1:4
with dilution buffer (100 mM HEPES, pH 7.5, 1 mM DTT,
2 mM PMSF, 20% glycerol, 10 mM glycerophosphate, 1 mM
Na3VO4, 1 mM NaF, 2 mg/ml leupeptin, 1 mg/ml pepstatin and
1 mg/ml bestatin). Aliquots containing 40 mg of the diluted
extract were loaded in parallel onto either a BSA (control) or
a Pol l column. The columns were washed with 2 column
volumes with a buffer containing 50 mM Tris–HCl, pH 7.5,
100 mM NaCl, 10 mM MgCl2, 10% glycerol, 1 mM PMSF,
1 mM DTT and 0.05% NP-40. Subsequently, the bound pro-
teins were eluted with the above mentioned buffer containing,
respectively, 150, 350 and 750 mM NaCl. Fractions (20 ml)
were analyzed by western blot by using different antibodies.
Antibodies
Antibodies against Cdk2 (sc-748) and PCNA (clone PC10)
were purchased from Santa Cruz Biotechnology and a-tubulin
(T-6199) from Sigma.
Immunoprecipitation experiments
Total extracts from HeLa cells were prepared as described
above. An aliquot of 1.5 mg of total extract was diluted 1:4
in buffer A (10 mM Tris–HCl, pH 7.5, 2.5 mM MgCl2, 0.5%
NP-40, 1 mM Na3VO4, 1 mM NaF, 1 mM PMSF, 2 mg/ml
leupeptin, 1 mg/ml pepstatin and 1 mg/ml bestatin) to yield a
final concentration of 100 mM NaCl and were then incubated
with 2 mg of antibodies against Cdk2 or 2 mg of rabbit IgG
(Vector Laboratories) as a negative control for 3 h at 4C.
Then, 25 ml of protein G-Sepharose (Amersham Biosciences)
coated with BSA were added for 1 h at 4C. The samples were
centrifuged for 30 min at 13 000 g at 4C and the pellets
washed three times for 10 min at 4C with a buffer containing
50 mM Tris–HCl, pH 8, 50 mM NaCl, 75 mM KCl, 0.1%
NP-40, 2 mg/ml leupeptin, 1 mg/ml pepstatin and 1 mg/ml
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bestatin. After immunoprecipitation the proteins were heated
5 min at 95C in Laemmli buffer and analyzed by SDS–PAGE
and western blot.
Pull-down assay
Pull-down experiments were performed by incubating 750 ng
of GST-Cdk2 with His-tagged Pol l bound to Ni2+-NTA beads
or with Ni2+-NTA beads alone as a control, for 2 h at 4C
in 40 mM Tris–HCl, pH 7.5, 100 mM NaCl, 0.1% (v/v) NP-
40, 5 mM imidazole, 2 mg/ml leupeptin, 1 mg/ml pepstatin and
1 mg/ml bestatin. After washing four times with the same
buffer, the beads were heated for 5 min at 95C in Laemmli
buffer and the co-precipitated proteins analyzed by western
blot using the corresponding antibodies.
Enzymatic assays
Kinase assay. Phosphorylation was carried out in a final
volume of 15 ml containing kinase buffer [50 mM Tris–
HCl, pH 7.5, 10 mM MgCl2, 0.5 mM [g-32P]ATP (3000 mCi/
mmol)], 66.6 mM ATP, in the presence of substrate (Histone
H1 or His-Pol l) and 40 ng of purified Cdk/cyclin complexes.
Reactions were carried out for 20 min at 37C, and the pro-
teins separated on a 10% SDS–PAGE. The gel was stained by
Coomassie brilliant blue, dried and exposed to an X-ray film.
The incorporation of [g-32P]ATP in Pol l polypeptide was
determined by cutting out the band corresponding to Pol l
after Coomassie staining, and by measuring the radioactivity
by liquid scintillation counting. Background was determined
by cutting out the band corresponding to Pol l incubated in the
reaction mixture in the absence of Cdk/cyclin complex and
subtracted from the obtained measurements. Pmols of incor-
porated radioactivity were calculated according to the specific
activity of the [g-32P]ATP used in the assay.
DNA polymerase assay
Product analysis by His-Pol l in the linear kinetic region was
performed using a sequencing gel. The reaction mixture
included in a final volume of 10 ml: 50 mM Tris–HCl, pH
7.5, 50 mM NaCl, 1 mM MnCl2 and 10 mM of each unlabeled
dNTPs, 20 fmol [32P]50 end-labeled 17mer primer annealed to
the d73mer template (see above). Reactions were incubated for
15 min at 37C, stopped by addition of sequencing gel loading
buffer [95% (v/v) formamide, 20 mM EDTA, pH 8.0] and
heated for 5 min at 95C. The reaction products were resolved
on a 10% polyacrylamide, 7 M urea gel. The gels were dried
and exposed to an X-ray film.
Phosphatase treatment
HeLa cells were grown as previously described, washed once
with ice-cold PBS, scraped off the dish and collected in ice-
cold PBS. The cells were spinned down, the packed cell vol-
ume (PCV) was estimated and the cells were resuspended in 1
PCV of buffer [50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1%
(v/v) Triton X-100, 0.5 mM PMSF, 2 mg/ml leupeptin, 1 mg/ml
pepstatin and 1 mg/ml bestatin]. After incubation on ice for
15 min the samples were centrifuged for 10 min at 10 000 g at
4C, and the supernatants kept as cell lysates. The phosphatase
assay was carried out in a volume of 20 ml containing 25 mg of
cell lysate, the l-phosphatase mixture (50 mM Tris–HCL,
pH 7.5, 0.1 mM Na2EDTA, 5 mM DTT, 0.01% Brij 35 and
2 mM MnCl2) and 400 U of l-phosphatase (New England
Biolabs). Incubation was at 30C for 45 min. Two negative
controls were added one without l-phosphatase and the other
with l-phosphatase in the presence of the phosphatase inhib-
itors EDTA (5 mM) and Na3VO4 (1 mM). Then, 2· Laemmli
buffer was added, the samples were heated at 90C for 2 min
and loaded on a 10% SDS–PAGE gel. The shift of the
phospho-band was analyzed by western blot by using the
corresponding antibodies.
RESULTS
DNA polymerase l interacts with Cdk2 in vitro and
in vivo
First, we searched for novel partners of Pol l by affinity
chromatography. His-Pol l or BSA were covalently bound
on HiTrap NHS-activated Sepharose HP columns. Total
extracts of HeLa cells were prepared as described in Materials
and Methods and loaded in parallel onto the two affinity col-
umns. Bound proteins were eluted successively by 150, 350
and 750 mM NaCl. The purification was carried out essentially
by following the PCNA elution, a protein known to interact
with Pol l in vitro (9) and in vivo (16). The elution profiles of
BSA and Pol l are shown in Figure 1A. Proteins binding
unspecifically were eluted in peak 1 at low NaCl concentra-
tions from the Pol l and the BSA columns. Two additional
peaks were exclusively present in the Pol l column elution.
They contained proteins eluted at higher NaCl concentration,
suggesting that they interact specifically with Pol l. The eluted
fractions were tested by western blot by using different anti-
bodies. We first confirmed that, as expected, PCNA specific-
ally bound to the Pol l column (data not shown). Next, we
found that the cyclin-dependent kinase Cdk2 was eluted in
peak 2 (fractions 24–28) from the Pol l column (Figure 1B),
whereas it bound only unspecifically to the BSA column
(peak 1). We further confirmed this interaction in vitro by a
His pull-down experiment. For this, GST-Cdk2 was incubated
with His-Pol l bound to Ni-beads or with Ni-beads alone as a
negative control (Figure 1C). Western blot analysis against
Cdk2 showed a specific co-precipitation of Pol l with Cdk2,
suggesting a direct interaction of these two proteins. Finally,
the interaction was tested in vivo by immunoprecipitation.
Anti-Cdk2 or control IgG bound to protein G-Sepharose
was incubated with HeLa cells total extracts. After immuno-
precipitation, western blot against Pol l showed that Pol l was
co-immunoprecipitated with Cdk2 only when the anti-Cdk2
antibody was used (Figure 1D). In summary, these results
indicate that Cdk2 can physically interact with Pol l in vitro
and in vivo.
DNA polymerase l is phosphorylated by the Cdk2/cyclin E,
Cdk2/cyclin A and Cdk1/cyclin A complexes in vitro
Next, we searched for potential Cdk phosphorylation sites in
the amino acid sequence of Pol l. We found three serines
(amino acids 167, 177 and 230, respectively) which could
be part of consensus sites for Cdk phosphorylation. They
are all located in the proline-serine-rich domain of Pol l.
These sites are specific to Pol l, since they do not occur in
the sequence of any of the other Pol X family members
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(Figure 2A). In order to verify whether Pol l could be a
substrate for Cdk-dependent phosphorylation, kinase assays
with different Cdk/cyclin complexes were performed in the
presence of recombinant Pol l and [g-32P]ATP. As shown in
Figure 2B, a [32P]labeled band of the expected molecular
weight for Pol l appeared after incubation with the Cdk2/
cyclin E, Cdk2/cyclin A and Cdk1/cyclin A complexes. His-
tone H1 was used as a positive control. The identity of the
phosphorylated band with Pol lwas confirmed by SDS–PAGE
and immunoblot analysis (data not shown, and Figures 1D and
3B, left panel). In summary, these results suggest that Pol l
is a target for phosphorylation by these three Cdk/cyclin
complexes in vitro.
The proline-serine-rich domain of DNA polymerase l is
the target of phosphorylation by Cdk2/cyclin A
In order to map the phosphorylation domains of Pol l,
kinase assays were performed by using deletion mutants of
Pol l (illustrated in Figure 3A). Figure 3B (left panel) shows
a Coomassie staining of the samples after the phosphoryla-
tion reaction separated by SDS–PAGE. The same gel was then
exposed to an X-ray film to reveal the phosphorylated
products. As shown in Figure 3B (right panel), Pol l, deleted
for the BRCT domain, was still phosphorylated by Cdk2/
cyclin A, whereas the mutant missing both the BRCT and
proline-serine-rich domain was not. This result supported
our findings that the three potential sites of phosphorylation
are located in the proline-serine-rich domain (see Figure 2A)
and suggested that this domain of Pol l is the target for Cdk2/
cyclin A.
Phosphorylation of DNA polymerase l does not affect its
polymerase activity and is regulated by its interaction
with PCNA
Furthermore, the effect of Pol l phosphorylation on its
polymerase activity was tested. For this, His-Pol l was
Figure 1. DNA polymerase l interacts with Cdk2 in vitro and in vivo. (A) Elution profile of BSA and Poll affinity columns. Aliquots containing 40 mg of HeLa cells
total extract were each loaded in parallel onto a BSA and Pol l affinity column, respectively. Bound proteins were eluted successively by 150, 350 and 750 mM NaCl.
(B) Aliquots containing 20 ml elution fractions from the BSA and Pol l columns were loaded on a SDS–PAGE gel and a western blot against Cdk2 was performed.
(C) His-Pol l interacts with GST-Cdk2 in vitro. Pull-down experiments were performed by incubating 750 ng of GST-Cdk2 with His-tagged Pol l bound to Ni2+-
NTA beads or with Ni2+-NTA beads alone (Control), for 2 h at 4C. After washing four times with the same buffer, the beads were heated for 5 min at 95C in Laemmli
buffer and the co-precipitated proteins were analyzed by western blot. The ‘Input 10%’ lane shows 10% of the total amount of GST-CDK2 used in the pull-down.
(D) Pol l and Cdk2 interact in vivo. Aliquots containing 1.5 mg of total HeLa cell extract were incubated with 2 mg of antibody against Cdk2 or 2 mg of rabbit IgG as a
negative control for 3 h at 4C. Then, 25ml of protein G-Sepharose were added for 1 h at 4C. Immunoprecipitated proteins were heated for 5 min at 95C and analyzed
by SDS–PAGE and western blot. The ‘Input 10%’ lane shows the signal obtained when 10% of the amount of cell extract used in the immunoprecipitation were loaded
on the gel.
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phosphorylated in vitro by Cdk2/cyclin A in the presence of
ATP. Preliminary experiments showed that the degree of Pol l
phosphorylation was between 56 and 84% considering that it
can be phosphorylated on one to three sites (see Materials and
Methods). This suggested that any effect due to phosphoryla-
tion of Pol l could be visualized by the sensitive method of
product analysis. As negative controls, His-Pol l was either
incubated in the presence of Cdk2/cyclin A without ATP, or in
the presence of ATP without Cdk2/cyclin A. The Pol l poly-
merase activity was then tested on a 50-labeled d17:d73mer
primer-template and the elongation products were visualized
on a polyacrylamide denaturating gel. DNA synthesis by Pol l
was stimulated when it was incubated with ATP, either alone
(lanes 7–9) or in combination with Cdk2/cyclin A (Figure 4A,
lanes 1–3), compared with the reactions where ATP was omit-
ted (lanes 4–6, lanes 10–12). Stimulation was greater when
Pol l was incubated in the presence of ATP alone (lanes 7–9),
suggesting that the observed stimulation was rather due to the
presence of ATP than to phosphorylation. This effect could be
explained by the fact that Pol l, similarly to Pol m (24), is able
to incorporate ribonucleotides opposite a DNA template
(K. Ramadan and U. Hu¨bscher, unpublished data). In this case,
ATP could be used as a nucleotide substrate by Pol l, thus
explaining the increased product elongation observed upon
addition of ATP (Figure 4A, lanes 7–9). Moreover, the slight
decrease in the effect of ATP in the presence of Cdk2/cyclin A
may be due to its consumption occurring upon Pol l phos-
phorylation (Figure 4A, lanes 1–3). From these results, we
concluded that phosphorylation of Pol l by Cdk2/cyclin A
does not directly affect its polymerase activity. In addition,
by testing the effect of phosphorylation on Pol l terminal
deoxynucleotidyl transferase activity, we showed that phos-
phorylation did not affect this activity (data not shown).
Since Pol l and PCNA have been shown to interact in vivo
and in vitro (9,16), and PCNA is known to interact with Cdk/
cyclin complexes (19), we next tested the effect of PCNA on
Figure 2. DNA polymerase l is phosphorylated by Cdk2/cyclin E, Cdk2/cyclin
A and Cdk1/cyclin A complexes in vitro. (A) Multiple amino acid alignment of
the human Pol X family and potential Cdk phosphorylation sites in Poll. (B) Pol
l is a substrate of Cdk2/cyclin E, Cdk2/cyclin A and Cdk1/cyclin A. Aliquots
containing 500 ng of Pol l or 100 ng Histone H1 were incubated in a kinase
buffer in the presence of 40 ng of different Cdk/cyclin complexes for 20 min at
37C. Proteins were then separated on a 10% SDS–PAGE, the gel stained by
Coomassie brilliant blue, dried and exposed to an X-ray film.
Figure 3. The proline-serine-rich domain of DNA polymerase l is the target of
phosphorylation by Cdk2/cyclin A. (A) Schematic domain organization of Poll
wt and deletion mutants. (B) Kinase assay by Cdk2/Cyclin A. Aliquots contain-
ing 500 ng of Pol l wt and deletion mutants or 100 ng Histone H1 were
incubated in a kinase buffer containing 40 ng of Cdk2/Cyclin A complex
for 20 min at 37C. Proteins were then separated on a 10% SDS–PAGE, the
gel stained by Coomassie brilliant blue (left panel), dried and exposed to an
X-ray film (right panel).
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phosphorylation of Pol l. Incubation of Pol l with PCNA
during phosphorylation by Cdk2/cyclin A in vitro resulted
in a decrease in Pol l phosphorylation (Figure 4B, upper
panel). However, when the same experiment was performed
by using the SHV43 PCNA mutant (18), no decrease of the
Pol l phosphorylation was observed (Figure 4B, lower panel).
In both cases, Pol l phosphorylation was abolished by addition
of the specific Cdk inhibitor p21, confirming that phosphoryla-
tion was due to Cdk2/cyclin A. It has been shown that the
PCNA mutant SHV43, in which the residues S43, H44 and
V45 in the hydrophobic pocket on the C-side of the trimer
were changed to A (18), is no more able to interact with Pol l
(16) but can still bind Cdk2 (25). Thus, this result suggested
that the physical interaction of PCNA with Pol l prevented
phosphorylation by Cdk2/cyclin A, suggesting a possible regu-
lation of the Pol l phosphorylation status via its interaction
with PCNA.
DNA polymerase l is phosphorylated during the
cell cycle
Having shown that Pol l can be phosphorylated by Cdk/cyclin
complexes in vitro, the next step was to test whether Pol l is
phosphorylated during the cell cycle. For this, HeLa cells were
synchronized at the G1/S transition by double thymidine
block, and subsequently released in normal medium. Samples
were collected at four different time points: 3 h (corresponding
to mid-S phase), 6 h (late S phase), 9 h (G2 phase) and 12 h
(G2/M phase). Synchronization in M phase was performed by
treatment of the cells with nocodazole. Cells released in
normal medium progressed in G1 phase and were collected
after 4 h. Synchronization was confirmed on total extracts by
western blot using antibodies against cyclin A, a specific mar-
ker of S and G2 phases of the cell cycle (Figure 5A, lower
panel). A western blot against Pol l using cell extracts from
synchronized cells revealed the presence of two forms of
Pol l, represented by a faster and a slower migrating band,
throughout the cell cycle. In S phase, the faster migrating
band was more abundant, whereas in late G2 and M phases,
only the slower migrating band could be detected (Figure 5A,
upper panel). To verify that these two different forms of Pol l
were due to phosphorylation, we treated a total extract of
S phase HeLa cells with bacteriophage l-phosphatase. In
Figure 4. Phosphorylation of DNA polymerase l does not affect its polymerase
activity and is regulated by its interaction with PCNA. (A) Product analysis of
DNA synthesis by phosphorylated and non-phosphorylated Pol l (75, 150 and
300 ng) on a d17:d73mer (20 fmol). His-Pollwas incubated in kinase buffer for
20 min at 37C with 40 ng Cdk2/cyclin A either with ATP (350 mM) (lanes 1–3,
phosphorylated Pol l) or without ATP (lanes 4–6, non-phosphorylated Pol l).
Two controls were added where His-Pol l was incubated in kinase buffer
without Cdk2/cyclin A but with (lanes 7–9) or without (lanes 10–12) ATP.
Positions of the 17mer and 73mer are indicated on the right side of the figure.
(B) Effect of the interaction between Pol l and PCNA on phosphorylation of
Poll by Cdk2/cyclin A. Aliquots containing 500 ng of His-Pollwere incubated
with 0, 500 or 750 ng of PCNA wt (upper panel, lanes 1–3) or the same amount
of PCNA SHV43 mutant (lower panel, lanes 1–3) for 5 min on ice followed by a
kinase assay by Cdk2/cyclin A. In each experiment, a control was performed in
the presence of the p21 inhibitor (750 ng, lane 4). Proteins were then separated
on a 10% SDS–PAGE, the gel stained by Coomassie brilliant blue, dried and
exposed to an X-ray film.
Figure 5. DNA polymerase l is phosphorylated during the cell cycle.
(A) Synchronization of HeLa cells at the G1/S border was achieved by double
blocks of thymidine (2 mM). After thymidine removal, cells were harvested
immediately (G1/S border) or further cultured in complete medium for 3 h
(S phase), 6 h (late S phase), 9 h (G2 phase) or 12 h (G2/M phase). Synchro-
nization in M phase was obtained by growing cells in nocodazole 40 ng/ml for
20 h. Cells were harvested immediately after nocodazole removal (M phase) or
further cultured in complete medium for 4 h (G1 phase). The cells were lysed in
500ml Laemmli buffer and 20ml extract were loaded on a 7.5% SDS–PAGE and
analyzed by western blot with antibodies against cyclin A, Pol l and a-tubulin,
respectively. a-tubulin was used as loading control. (B) Aliquots containing
25mg of total extract from HeLa cells synchronized in S phase were treated with
or without 400 U of bacteriophage l-phosphatase for 45 min at 30C.
The reaction was stopped by adding Laemmli buffer and the samples were
loaded on a 7.5% SDS–PAGE and analyzed by western blot with antibodies
against Pol l and tubulin.
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the presence of the phosphatase only one form of Pol l was
visible (Figure 5B, lane 1), corresponding to the faster
migrating form, as revealed by comparison with reaction
without phosphatase (lane 2) or in the presence of phosphatase
inhibitors (lane 3), suggesting that Pol l is phosphorylated
in vivo and that its phosphorylation status is modulated during
cell cycle.
DISCUSSION
In our efforts to better understand the Pol l function, we
searched for partners by affinity chromatography and we
found Cdk2 as a novel interacting partner of Pol l. Analysis
of the amino acid sequence of Pol l revealed the presence of
three potential phosphorylation sites (S167, S177 and S230)
for Cdk in its proline-serine-rich domain and we showed that
this domain is the target of phosphorylation of Pol l by the
Cdk2/cyclin A complex. This finding is not unexpected, since
in other proteins proline-rich domains have been shown to be
targets of post-translational modifications and to be involved
in the regulation of protein function. Moreover, we found that
Pol l is phosphorylated during the cell cycle and exists in two
forms in S phase with a majority of hypophosphorylated form,
whereas it is present exclusively in its hyperphosphorylated
form from G2 to M phase (Figure 5). The different phos-
phorylation status of Pol l could be linked with different
Pol l functions in vivo. Interestingly, Pol l is mainly present
in the hypophosphorylated form in the S phase of the cell cycle
when PCNA is also abundant. This is in agreement with our
findings that the presence of PCNA reduces Pol l phos-
phorylation in vitro and suggests that this regulation may
also happen in vivo.
In terms of physiological role, it has been shown that PCNA
stimulated translesion synthesis of Pol l past an abasic site as
it did for Pol i, Pol k and Pol h but by a different mechanism of
interaction. Thus, it is tempting to speculate that the interplay
among Cdk2/cyclin A, PCNA and Pol l, revealed by our
study, might act in regulating the ‘switch’ between the rep-
licative Pol d an the translesion Pol l through direct competi-
tion for PCNA, yielding to elongation of the nascent DNA
strand past abasic sites. This model was supported by the
finding that Pol l interacts with PCNA at the same site as
Pol d and many other partners and that PCNA could promote
bypass of abasic sites during DNA replication (9,16). More-
over, we showed that phosphorylation of Pol l does not influ-
ence its polymerase activity, suggesting that phosphorylation
of Pol l rather regulates its interaction with cellular factors
(e.g. PCNA) than its intrinsic activity.
In summary, our results allow to hypothesize that regulation
of Pol l phosphorylation by PCNA during the cell cycle may
be important in modulating the interaction of Pol l with other
protein partners, or its recruitment to specific sites on chro-
matin. The effect of Cdk/cyclin phosphorylation on several
replication proteins has been studied and seems to be specific
for each protein [reviewed in (26)]. For example, phosphoryla-
tion has an inhibitory or stimulatory effect on the activity on
Pol a depending on which Cdk/cyclin complexes phos-
phorylate it (27). In other cases, phosphorylation has been
shown to regulate interaction between proteins, such as Fen 1
(28) or DNA ligase I (29,30), with PCNA. In addition,
phosphorylation of replication protein A (RP-A) by Cdk1/
cyclin A and Cdk1/cyclin B in late S phase leads to the
dissociation of the RP-A trimer (31).
The interaction between Cdk2 and Pol l also fits with the
proposed role of Pol l in non-homologous end joining (14,15).
In fact, Cdk2 has been recently shown to regulate DNA DSB
repair when associated to cyclin A1. Cyclin A1 is a second
A-type cyclin abundantly expressed in testis (32,33). Since
Pol l is also known to be abundant in testis (34) one could
propose a role of Pol l in DSB repair in germ cells. Additional
observations of Cdk2 localization at the telomeric ends of
chromosome from leptotene to diplotene stage of meiosis
(35) could support a role of Pol l by its terminal transferase
activity (7) in germ cells. In addition, our data are supported by
the recent findings that Pol l is selectively involved in NHEJ
processing DNA with complementary overhangs, which occur
upon DNA damage, whereas Pol m seems to be mainly
involved in NHEJ of DNA with non-complementary ends
(36). In this context, phosphorylation of Pol l may be one
of the factors influencing selectively the recruitment of Pol l
on places where its activity is needed.
In conclusion, we showed for the first time that Pol l is post-
translationally modified in human cells, and that this modi-
fication is regulated during the cell cycle, opening a way for a
better understanding of the Pol l function in vivo.
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